Target Name: ZNF571
NCBI ID: G51276
Review Report on ZNF571 Target / Biomarker Content of Review Report on ZNF571 Target / Biomarker
ZNF571
Other Name(s): Zinc finger protein 571 | HSPC059 | ZN571_HUMAN | zinc finger protein 571 | ZNF571 variant 2 | Zinc finger protein 571, transcript variant 2

ZNF571: A Potential Drug Target and Biomarker

Introduction

Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in various cellular processes. ZNF571, a member of the ZNF family, is a protein that has been identified as a potential drug target and biomarker. In this article, we will explore the structure and function of ZNF571, its potential drug targets, and its potential as a biomarker for various diseases.

Structure and Function

ZNF571 is a 21 kDa protein that contains a N-terminal zinc finger domain, a central transmembrane domain, and a C-terminal T-loop domain. The N-terminal zinc finger domain is a conserved structural feature that is found in various proteins, including ZNF571. This domain plays a crucial role in ZNF571's stability and functions as a structural anchor. The central transmembrane domain is responsible for ZNF571's transmembrane properties and is involved in its interaction with various signaling pathways. The C-terminal T-loop domain is a conserved structural feature that is found in various proteins, including ZNF571. This domain plays a crucial role in ZNF571's stability and functions as a structural anchor.

Functional assays have shown that ZNF571 is involved in various cellular processes, including cell signaling, DNA replication, and cell growth. ZNF571 has been shown to play a role in the regulation of cell proliferation and has been shown to interact with various signaling pathways, including the TGF-β pathway.

Potential Drug Targets

ZNF571 is a protein that has been shown to interact with various drug targets, including TGF-β, NF-kappa-B, and p53. This suggests that ZNF571 may be a drug target for diseases that are characterized by the over-expression or deregulation of these signaling pathways.

One potential drug target for ZNF571 is the TGF-β pathway. The TGF-β pathway is a signaling pathway that plays a role in the regulation of cell proliferation, differentiation, and survival. ZNF571 has been shown to interact with the TGF-β receptor , leading to the regulation of cell proliferation and survival.

Another potential drug target for ZNF571 is the NF-kappa-B pathway. The NF-kappa-B pathway is a signaling pathway that plays a role in the regulation of inflammation, pain, and other cellular processes. ZNF571 has been shown to interact with the NF-kappa-B receptor, leading to the regulation of inflammation and pain.

In addition to its potential drug targets, ZNF571 has also been shown to be a potential biomarker for various diseases. For example, ZNF571 has been shown to be involved in the regulation of cell proliferation, which may be an indicator of cancer progression. , ZNF571 has been shown to be involved in the regulation of inflammation and pain, which may be indicators of various inflammatory diseases.

Conclusion

ZNF571 is a protein that has been shown to play a role in various cellular processes and has been identified as a potential drug target and biomarker. Its N-terminal zinc finger domain, central transmembrane domain, and C-terminal T-loop domain give it a unique structure that allows it to interact with various signaling pathways. Further research is needed to fully understand the functions of ZNF571 and its potential as a drug target and biomarker.

Protein Name: Zinc Finger Protein 571

Functions: May be involved in transcriptional regulation

The "ZNF571 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF571 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF571-AS1 | ZNF572 | ZNF573 | ZNF574 | ZNF575 | ZNF576 | ZNF577 | ZNF578 | ZNF579 | ZNF580 | ZNF582 | ZNF582-DT | ZNF583 | ZNF584 | ZNF585A | ZNF585B | ZNF586 | ZNF587 | ZNF587B | ZNF589 | ZNF592 | ZNF593 | ZNF594 | ZNF594-DT | ZNF595 | ZNF596 | ZNF597 | ZNF598 | ZNF599 | ZNF600 | ZNF603P | ZNF605 | ZNF606 | ZNF607 | ZNF608 | ZNF609 | ZNF610 | ZNF611 | ZNF613 | ZNF614 | ZNF615 | ZNF616 | ZNF618 | ZNF619 | ZNF620 | ZNF621 | ZNF622 | ZNF623 | ZNF624 | ZNF625 | ZNF625-ZNF20 | ZNF626 | ZNF627 | ZNF628 | ZNF629 | ZNF630 | ZNF638 | ZNF639 | ZNF641 | ZNF644 | ZNF646 | ZNF648 | ZNF649 | ZNF652 | ZNF652-AS1 | ZNF653 | ZNF654 | ZNF655 | ZNF658 | ZNF658B | ZNF66 | ZNF660 | ZNF662 | ZNF663P | ZNF664 | ZNF664-RFLNA | ZNF665 | ZNF667 | ZNF667-AS1 | ZNF668 | ZNF669 | ZNF670 | ZNF670-ZNF695 | ZNF671 | ZNF672 | ZNF674 | ZNF674-AS1 | ZNF675 | ZNF676 | ZNF677 | ZNF678 | ZNF679 | ZNF680 | ZNF681 | ZNF682 | ZNF683 | ZNF684 | ZNF687 | ZNF688 | ZNF689